Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
18,38 EUR | -0,76 % | -2,13 % | +10,66 % |
Resumen de negocios
Número de empleados: 3 282
Ventas por actividad
EUR en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Fagron North America
40,5
%
| 245 | 35,8 % | 309 | 40,5 % | +25,99 % |
Fagron EMEA
37,3
%
| 276 | 40,4 % | 285 | 37,3 % | +3,08 % |
Fagron Latin America
22,2
%
| 162 | 23,7 % | 169 | 22,2 % | +4,25 % |
Ventas por región
EUR en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
North America
40,5
%
| 245 | 35,8 % | 309 | 40,5 % | +25,99 % |
EMEA
37,3
%
| 276 | 40,4 % | 285 | 37,3 % | +3,08 % |
Latin America
22,2
%
| 162 | 23,7 % | 169 | 22,2 % | +4,25 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Chief Executive Officer | 46 | 27/11/17 | |
Karin de Jong
DFI | Director of Finance/CFO | 45 | 01/05/08 |
Vera Bakker
COO | Chief Operating Officer | 52 | 09/05/22 |
Karen Berg
IRC | Investor Relations Contact | - | 01/09/21 |
Marc van der Aa
PRN | Corporate Officer/Principal | - | - |
Johan Verlinden
LAW | General Counsel | - | 01/04/13 |
Celine Caveye
HRO | Human Resources Officer | - | 01/01/11 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Koen Hoffman
CHM | Chairman | 56 | 01/08/16 |
Director/Board Member | 64 | 01/01/19 | |
Chief Executive Officer | 46 | 27/11/17 | |
Karin de Jong
DFI | Director of Finance/CFO | 45 | 01/05/08 |
Director/Board Member | 53 | 09/05/22 | |
Vera Bakker
COO | Chief Operating Officer | 52 | 09/05/22 |
Neeraj Sharma
BRD | Director/Board Member | 52 | 09/05/22 |
Director/Board Member | 53 | 01/01/22 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 73 228 904 | 69 227 472 ( 94,54 %) | 241 999 ( 0,3305 %) | 94,54 % |
Información de la empresa
Empresas del grupo
Nombre | Categoría y sector |
---|---|
FAGRON as
FAGRON as Pharmaceuticals: MajorHealth Technology FAGRON as operates as wholesaler of pharmaceutical raw materials, creams and packaging to pharmacists. The company was founded on May 11, 1992 and is headquartered in Olomouc, Czech Republic. |
Pharmaceuticals: Major
|
Dr. Kulich Pharma sro
Dr. Kulich Pharma sro Pharmaceuticals: MajorHealth Technology Dr. Kulich Pharma sro engages in the pharmaceuticals industry. It offers drugs, pharmaceutical materials, chemicals, as well as laboratory services. The company was founded by Jan Kulich in 1992 and is headquartered in Hradec Kralove, Czech Republic. |
Pharmaceuticals: Major
|
Arseus Capital NV
Arseus Capital NV Financial ConglomeratesFinance Part of Fagron NV, Arseus Capital NV provides financial services. The company is based in Nazareth, Belgium. The CEO of the Belgian company is Cornelia de Jong. |
Financial Conglomerates
|
Fagron BV
|
Ventas por actividad
Ventas por región
Revisiones del BPA
Beneficios anuales - Tasa de sorpresa
Varia. 1 de ene. | Capi. | |
---|---|---|
+10,66 % | 1456,09 M | |
+38,51 % | 727 mil M | |
+33,05 % | 599 mil M | |
-6,23 % | 354 mil M | |
+18,78 % | 328 mil M | |
+1,35 % | 277 mil M | |
+16,00 % | 243 mil M | |
+8,09 % | 205 mil M | |
-5,77 % | 203 mil M | |
+6,19 % | 164 mil M |
- Bolsa de valores
- Acciones
- Acción FAGR
- Empresa Fagron N.V.